Clinical Study
7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan
Table 4
Univariate analysis of the clinical factors influencing the efficacy of H. pylori eradication therapy.
| Principle parameter | No. of patients | Eradication rate | P value |
| Age | | | 0.762 | <60 years | 220 | 95.5% | | ≧60 years | 92 | 96.7% | | Sex | | | 0.010 | Female | 129 | 92.2% | | Male | 183 | 98.4% | | Smoking | | | 0.046 | (−) | 242 | 94.6% | | (+) | 70 | 100% | | Alcohol consumption | | | 0.610 | (−) | 290 | 95.5% | | (+) | 22 | 100% | | Ingestion of coffee | | | 0.294 | (−) | 231 | 96.5% | | (+) | 81 | 93.8% | | Ingestion of tea | | | 0.085 | (−) | 189 | 94.2% | | (+) | 123 | 98.4% | | NSAID use | | | 0.503 | (−) | 296 | 95.9% | | (+) | 16 | 93.8% | | Previous history of peptic ulcer | | | | (−) | | | | (+) | | | | Presence of ulcer | | | 0.314 | (−) | 65 | 94.9% | | (+) | 234 | 95.1% | | Compliance | | | 0.015 | (−) | 5 | 60% | | (+) | 307 | 96.4% | | Side effect | | | 0.082 | (−) | 270 | 96.7% | | (+) | 42 | 90.5% | |
|
|